Document is current
Any future updates will be listed below
-
Authors
Saridaki, Zacharenia
Fountzilas, Elena
Alexopoulos, Athanasios
Karachaliou, Niki
- License Information
-
More Information
Article History
Received: 8 March 2024
Accepted: 24 February 2025
First Online: 14 March 2025
Declarations
:
: Not applicable.
: Informed consent for publication was obtained from the next of kin of the deceased patients.
: Dr. Zacharenia Saridaki: No relevant conflicts of interest to disclose.Dr. Elena Fountzilas has the following financial relationships to disclose: Advisory Role: Amgen LEO Pharma. Speaker fees: Roche, Pfizer, AstraZeneca, Amgen. Travel grant: Astra Zeneca, Merck, Pfizer and DEMO. Stock ownership: Genprex Inc., Deciphera Pharmaceuticals Inc.Athanasios Alexopoulos: No relevant conflicts of interest to disclose.Dr. Niki Karachaliou: employee of the healthcare business of Merck KGaA, Darmstadt, Germany.
